Cytokinetics Inc (CYTK)
Net profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | -526,244 | -388,955 | -215,314 | -127,290 | -121,692 |
| Revenue | US$ in thousands | 7,530 | 72,481 | 53,988 | 39,865 | 20,245 |
| Net profit margin | -6,988.63% | -536.63% | -398.82% | -319.30% | -601.10% |
December 31, 2023 calculation
Net profit margin = Net income ÷ Revenue
= $-526,244K ÷ $7,530K
= -6,988.63%
The net profit margin of Cytokinetics Inc has shown a significant decline over the past five years, with negative values indicating that the company's expenses have exceeded its revenues consistently during this period. The highest negative net profit margin was recorded in 2023 at -6,988.63%, which suggests substantial losses compared to the revenues generated. This trend indicates challenges in controlling costs or generating sufficient revenue to cover expenses, impacting the company's overall profitability. It is essential for Cytokinetics Inc to address these issues and implement strategies to improve its financial performance and return to profitability.
Peer comparison
Dec 31, 2023